:::::::::::: Á¤½ÅÁúȯ °ü·Ã ÀÓ»ó½ÃÇè °á°ú ::::::::::::
ÃÑ ´ë»óÀÚ 267¸í
³²¼º 100¸í(¿¬·É 5-67¼¼, Æò±Õ 39¼¼)
16 ÀÔ¿øÈ¯ÀÚ
 
¿©¼º 167¸í(¿¬·É 9-86¼¼, Æò±Õ 42¼¼)
225 ¿Ü·¡È¯ÀÚ
   Alpha-Stim¿¡ ¾Õ¼­ ½ÃÇàµÈ Ä¡·á¹ý
36 ECT
6 ¹°¸®Ä¡·á
15 ÁøÁ¤¼ö¸éÁ¦
67 Á¤½ÅÄ¡·á
10 ¼ö¼ú
5 Á¤½ÅÀÚ±ØÁ¦
22 Çൿ¼öÁ¤
31 ±âŸ ºñ¾à¹°¿ä¹ý
27 ´ëÁ¤¿ÂÁ¦
2 ¹Ð¸®¾ÏÆä¾î TENS
34 ¾ËÄÚ¿Ã
9 ÁøÅëÁ¦
12 Ä«ÀÌ·ÎÇÁ·¢Æ½
28 Ç׺ҾÈÁ¦
6 NSAIDs
1 ½Å°æÂ÷´Ü
61 Ç׿ì¿ïÁ¦
10 ±ÙÀÌ¿ÏÁ¦
2 ¹ÙÀÌ¿ÀÇǵå¹é
24 ¸¶¾à
33 ±âŸ¾à¹°
   ÀÌÀü Ä¡·á¹ýÀ» Áß´ÜÇÑ ÀÌÀ¯
18 ¿©ÀüÈ÷ »ç¿ë
5 ¾ÇÈ­
13 ¾à¹°ºÎÀÛ¿ë
1 Ä¡·á¹ýº¯°æ
55 È¿°ú¾ø´Ù
9 ³Ê¹« ºñ½Î´Ù
1 Alpha-Stim »ç¿ë
16 ±âŸ
   ÀÌÀü Ä¡·á¹ýÀÇ ºÎÀÛ¿ë
33 ¾ø´Ù
7 ¾à¹°À» º¹¿ëÇÑ ´À³¦
9 ÁøÁ¤ÀÛ¿ë
0 ÅëÁõ
3 ¾à¹°¹Î°¨¼º/¾Ë·¹¸£±â
5 À§ÀåÀå¾Ö
5 Ž´Ð
5 Á¤½ÅÀÇ ¸ù·ÕÇÔ
12 ±âŸ

  Alpha-StimÀ» »ç¿ëÇØ¼­ ¾òÀº Ä¡·á °á°ú

ÁÖ¿äÁõ»ó
´ë»óÀÚ¼ö
¾ÇÈ­
º¯È­¾øÀ½
¾à°£
¶Ñ·Ç
Å«Çâ»ó
ÇöÀúÇÔ
¿ÏÄ¡
°³¼±È¿°ú
(neg)
(no change)
(<24%)
(25-49%)
(50-74%)
(75-99%)
(100%)
(>25%)
ÅëÁõ
89
0
0.00%
0
0.00%
3
3.37%
17
19.10%
26
29.21%
36
40.45%
7
7.87%
86
96.63%
ºÒ¾È
206
0
0.00%
1
0.49%
3
1.46%
22
10.68%
59
28.64%
111
53.88%
10
4.85%
202
98.06%
¿ì¿ïÁõ
102
0
0.00%
0
0.00%
3
2.94%
14
13.73%
25
24.51%
55
53.92%
5
4.90%
99
97.06%
½ºÆ®·¹½º
141
0
0.00%
0
0.00%
4
2.84%
20
14.18%
41
29.08%
69
48.94%
7
4.96%
137
97.16%
ºÒ¸éÁõ
70
0
0.00%
3
4.29%
2
2.86%
7
10.00%
20
28.57%
30
42.86%
8
11.43%
65
92.86%
µÎÅë
55
0
0.00%
2
3.64%
0
0.00%
5
9.09%
13
23.64%
29
52.73%
6
10.91%
53
96.36%
±ÙÀ°±äÀå
87
0
0.00%
0
0.00%
1
1.15%
17
19.54%
19
21.84%
42
48.28%
8
9.20%
86
98.85%